Intestinal rehabilitation and the short bowel syndrome: Part 2

American Journal of Gastroenterology

Volumn 99, Issue 9, 2004, Pages 1823-1832

  DiBaise, John K ^a   Young, Rosemary J ^a   Vanderhoof, Jon A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; CLONIDINE; CODEINE; DIPHENOXYLATE; GLUTAMINE; GROWTH HORMONE; HISTAMINE H2 RECEPTOR ANTAGONIST; LOPERAMIDE; MEDIUM CHAIN TRIACYLGLYCEROL; OCTREOTIDE; OPIATE; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ADAPTATION; BACTERIAL OVERGROWTH; BILIARY TRACT DISEASE; CALORIC INTAKE; CARBOHYDRATE INTAKE; CATHETER INFECTION; CENTRAL VEIN; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY FIBER; DIETARY INTAKE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ELECTROLYTE DISTURBANCE; ENERGY ABSORPTION; ESSENTIAL FATTY ACID DEFICIENCY; GASTROINTESTINAL ABSORPTION; GLUCOSE ABSORPTION; HORMONE ACTION; HUMAN; INTESTINE MOTILITY; INTESTINE RESECTION; INTESTINE SURGERY; KIDNEY DISEASE; LACTIC ACIDOSIS; LIPID ABSORPTION; LIVER DISEASE; LONG TERM CARE; MACRONUTRIENT; MALNUTRITION; METABOLIC BONE DISEASE; NEUROTOXICITY; NUTRIENT; PARENTERAL NUTRITION; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN INTAKE; QUALITY OF LIFE; REVIEW; SHORT BOWEL SYNDROME; SURGICAL APPROACH; SURVIVAL RATE; SURVIVAL TIME; THROMBOSIS;

ADAPTATION, PHYSIOLOGICAL; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DIET THERAPY; FEMALE; GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL REQUIREMENTS; PARENTERAL NUTRITION; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SHORT BOWEL SYNDROME; SICKNESS IMPACT PROFILE; SURVIVAL RATE;

EID: 4544342833     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40836.x     Document Type: Review

References (85)

1. Wolverkamp CJ, Heineman E, Taylor R, et al. Towards understanding the process of intestinal adaptation. Dig Dis 1996;14:59-72.
2. van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. Lancet 1993;341:1363-5.
3. Beaugererie L, Carbonnel F, Hecketsweiler B, et al. Effects of an isotonic oral rehydration solution, enriched with glutamine, on fluid and sodium absorption in patients with a short bowel. Aliment Pharmacol Ther 1997;11:741-7.
4. Scolapio JS, McGreevy K, Tennyson GS, et al. Effect of glutamine in short-bowel syndrome. Clin Nutr 2001;20:319-23.
5. Nordgaard I, Hansen BS, Mortensen PB. Importance of colonic support for energy absorption as small-bowel failure proceeds. Am J Clin Nutr 1996;64:222-31.
6. Finkel Y, Brown G, Smith HL, et al. The effects of a pectin-supplemented elemental diet in a boy with short gut syndrome. Acta Paediatr Scan 1990;79:983-6.
7. Byrne TA, Morrisey TB, Nattakom TV, et al. Growth hormone, glutamine and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr 1995;222:296-302.
8. Fuse K, Bamba T, Hosoda S. Effects of pectin on fatty acid and glucose absorption and on the thickness of the unstirred water layer in rat and human intestine. Dig Dis Sci 1989;34:1109-16.
9. Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998;43:478-83.
10. Lin HC, Van Citters GW, Heimer F, et al. Slowing of gastrointestinal transit by oleic acid. A preliminary report of a novel, nutrient-based treatment in humans. Dig Dis Sci 2001;46:223-9.
11. Kotler DP, Levine GM. Reversible gastric and pancreatic hyposecretion after long-term total parenteral nutrition. N Engl J Med 1979;300:241-2.
12. Gruy-Kapral C, Lettle KH, Fordtran JS, et al. Conjugated bile acid replacement therapy for short-bowel syndrome. Gastroenterology 1999;116:15-21.
13. Heydorn S, Jeppesen PB, Mortensen PB. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome. Scand J Gastroenterol 1999;34:818-24.
14. Ellegard L, Bosaeus I, Nordgren S, et al. Low-dose recombinant growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg 1997;22:88-96.
15. Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: A positive study. Gastroenterology 2003;124:293-302.
16. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001;120:806-15.
17. Byrne TA, Persinger RL, Young LS, et al. A new treatment for patients with short-bowel syndrome: Growth hormone, glutamine, and a modified diet. Ann Surg 1995;222:243-54.
18. Wilmore DW, Lacey JM, Soultanakis RP, et al. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg 1997;226:288-93.
19. Zhu W, Li N, Ren J, et al. Rehabilitation therapy for short bowel syndrome. Chin Med J 2002;115:776-8.
20. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short bowel syndrome: A randomized, controlled study. Gastroenterology 1997;113:1074-81.
21. Skudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: A randomized, double-blind, crossover, placebo-controlled study. Gut 2000;47:199-205.
22. Scolapio JS. Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: A randomized, controlled study. JPEN J Parenter Enteral Nutr 1999;23:309-12.
23. Jeppesen PB, Szkudlarek J, Hoy CE, et al. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acid status in short bowel patients: A randomized, double-blind, crossover, placebo-controlled study. Scand J Gastroenterol 2001;36:48-54.
24. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003;124:1111-34.
25. Vanderhoof JA, Langnas AN. Short-bowel syndrome in children and adults. Gastroenterology 1997;113:1767-78.
26. Allard JP, Jeejeebhoy KN. Nutritional support and therapy in the short bowel syndrome. Gastroenterol Clin North Am 1989;18:589-601.
27. Welters CFM, Dejong CH, Deutz NEP, et al. Intestinal adaptation in short bowel syndrome. Aust NZ J Surg 2002;72:229-36.
28. McIntyre PB, Fitchew M, Lennard-Jones JE. Patients with a high jejunostomy do not need a special diet. Gastroenterology 1986;91:25-33.
29. Norgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel. Lancet 1994;343:373-6.
30. Iyer K, DiBaise J, Horslen S, et al. Multidisciplinary approach to intestinal failure - Initial results. (abstract). Gastroenterology 2003;124:A432.
31. Fishbein TM, Schiano T, LeLeiko N, et al. An integrated approach to intestinal failure. Results of a new program with total parenteral nutrition, bowel rehabilitation, and transplantation. J Gastrointest Surg 2002;6:554-62.
32. Byrne TA, Veglia L, Camelio M, et al. Beyond the prescription: Optimizing the diet of patients with short bowel syndrome. Nutr Clin Pract 2000;15:306-11.
33. Byrne TA, Cox S, Karimbakas MN, et al. The role of diet and specific nutrients. In: Steiger E, Matarese L, eds. Intestinal failure and rehabilitation: A clinical guide. Boca Raton, FL: CRC Press LLC. (in press).
34. Spiller RC, Jones BJM, Silk DB. Jejunal water and electrolyte absorption from two proprietary enteral feeds in man: Importance of sodium content. Gut 1987;28:681-7.
35. Sladen GE, Dawson AM. Inter-relationships between the absorptions of glucose, sodium and water by the normal human jejunum. Clin Sci 1969;36:119-32.
36. Rodrigues Ca, Lennard-Jones JE, Thompson DG, et al. What is the ideal sodium concentration of oral rehydration solutions for short bowel patients. Clin Sci 1988;74:69.
37. Treatment and prevention of dehydration in diarrhea diseases: A guide for use at the primary level. WHO: Geneva, 1976.
38. Marteau P, Messing B, Arrigoni E, et al. Do short bowel patients need a lactose-free diet? Nutrition 1997;13:13-6.
39. Nightingale JMD, Lennard-Jones JE, Gertner DJ, et al. Colonic preservation reduces the need for parenteral therapy, increases the incidence of renal stones but does not change the high prevalence of gallstones in patients with a short bowel. Gut 1992;33:1493-7.
40. Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998;43:478-83.
41. Jeppesen PB, Howy CE, Mortensen PB. Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure. Eur J Clin Nutr 2000;54:632-42.
42. Williams NS, Evans P, King RFGJ. Gastric acid secretion and gastrin production in the short bowel syndrome. Gut 1985;26:914-9.
43. Fried M, Siegrist H, Frei R, et al. Duodenal bacterial over-growth during treatment in outpatients with omeprazole. Gut 1994;35:23-6.
44. Cooper JC, Williams NS, King RF, et al. Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhea. Br J Surg 1986;73:128-31.
45. Ladefoged K, Christensen KC, Hegnhoj J, et al. Effect of a long-acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut 1989;30:943-9.
46. Nehra V, Camilleri M, Burton D, et al. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol 2001;96:1494-8.
47. O'Keefe SJD, Haymond MW, Bennet WM, et al. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology 1994;107:379-88.
48. Sukhotnik I, Khateeb K, Krausz MM, et al. Sandostatin impairs postresection intestinal adaptation in a rat model of short bowel syndrome. Dig Dis Sci 2002;47:2095-102.
49. Vanderhoof JA, Kollman KA. Lack of inhibitory effect of octreotide on intestinal adaptation in short bowel syndrome in the rat. J Pediatr Gastroenterol Nutr 1998;26:241-4.
50. Newton CR. Effect of codeine phosphate, lomotil and isogel on ileostomy function. Gut 1978;19:377-83.
51. King RFGJ, Norton T, Hill GL. A double-blind crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output. Aust N Z J Surg 1982;52:121-4.
52. Rovera G, Furukawa H, Reyes J, et al. The use of clonidine for the treatment of high intestinal output following small bowel transplantation. Transplant Proc 1997;29:1853-4.
53. Nightingale JMD, Lennard-Jones JE, Walker ER. A patient with jejunostomy liberated from home intravenous therapy after 14 years; contribution of balance studies. Clin Nutr 1992;11:101-5.
54. Little KH, Schiller LR, Bilhartz LE, et al. Treatment of severe steatorrhea with ox bile in an ileectomy patient with residual colon. Dig Dis Sci 1992;37:929-33.
55. Heydorn S, Jeppesen PB, Mortensen PB. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome. Scand J Gastroenterol 1999;34:818-23.
56. Hoffman AF, Poley R. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. Gastroenterology 1972;62:918-34.
57. Vanderhoof JA, Young RJY. Antimicrobials and probiotics. In: Steiger E, Matarese L, eds. Intestinal failure and rehabilitation: A clinical guide. Boca Raton, FL: CRC Press LLC (in press).
58. Toskes PP, Giannella RA, Jervis HR, et al. Small intestinal mucosal injury in the experimental blind loop syndrome. Light- and electron-microscopic and histochemical studies. Gastroenterology 1975;68:193-203.
59. Giannella RA, Rout WR, Toskes PP. Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterology 1974;67:965-74.
60. Dahshan A, Donovan K. Auto-brewery syndrome in a child with short gut syndrome: Case report and review of the literature. J Pediatr Gastroenterol Nutr 2001;33:214-5.
61. Vanderhoof JA, Young RJ, Murray N, et al. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 1998;27:155-60.
62. Thompson JS, Vanderhoof JA, Antonson DL. Intestinal tapering and lengthening for short bowel syndrome. J Pediatr Gastroenterol Nutr 1985;4:495-7.
63. Kanamori Y, Hashizume K, Sugiyama M, et al. Combination therapy with bifidobacterium breve, lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: A novel synbiotics therapy. Dig Dis Sci 2001;46:2010-6.
64. Quigley EMM, Marsh MN, Shaffer JL, et al. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993;104:286-301.
65. Howard L, Ashley C. Management of complications in patients receiving home parenteral nutrition. Gastroenterology 2003;124:1651-61.
66. Carbonnel F, Cosnes J, Chevret S, et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr 1996;20:275-80.
67. Scolapio JS, Fleming CR, Kelly DG, et al. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clin Proc 1999;74:217-22.
68. Messing B, Lemann M, Landais P, et al. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology 1995;108:1005-10.
69. Messing B, Crenn P, Beau P, et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999;117:1043-50.
70. Crenn P, Coudray-Lucas C, Thuillier F, et al. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000;119:1496-505.
71. Weseman R, DiBaise JK, Sudan D, et al. Successful restoration of nutritional autonomy in short bowel syndrome (SBS) patients with very low plasma citrulline concentration. (abstract). Nutr Clin Prac 2004;19:86(abstract).
72. Booth CC. The effects of intestinal resection in man. Postgrad Med J 1961;37:725-39.
73. Cosnes J, Carbonnel F, Beaugerie L, et al. Functional adaptation after extensive small bowel resection in humans. Eur J Gastroenterol Hepatol 1994;6:197-202.
74. Scolapio JS. Tales from the crypt. Gastroenterology 2003;124:561-4.
75. Byrne TA, Lautz DB, Iyer KR, et al. Recombinant human growth hormone reduces parenteral nutrition (PN) requirements in patients with the short bowel syndrome: A prospective, randomized, double-blind, placebo-controlled study. (abstract). JPEN J Parenter Enteral Nutr 2003;27:S17.
76. Litvak DA, Iseki H, Evers M, et al. Characterization of two novel proabsorptive peptide YY analogs, BIM-43073D and BIM-43004C. Dig Dis Sci 1999;44:643-8.
77. Thompson JS. Reoperation in patients with the short bowel syndrome. Am J Surg 1992;164:453-7.
78. Thompson JS. Strategies for preserving intestinal length in the short bowel syndrome. Dis Colon Rectum 1987;30:208-13.
79. Devine RM, Kelly KA. Surgical therapy of the short bowel syndrome. Gastroenterol Clin North Am 1989;18:603-18.
80. Fishbein TM, Gondolesi GE, Kaufman SS. Intestinal transplantation for gut failure. Gastroenterology 2003;124:1615-28.
81. Gilroy R, Sudan D. Liver and small bowel transplantation: Therapeutic alternatives for the treatment of liver disease and intestinal failure. Semin Liver Dis 2000;20:437-50.
82. Iyer KR, Iversen AI, DeVoll-Zabrocki A, et al. Pediatric intestinal transplantation-Review of current practice. Nutr Clin Pract 2002;17:350-60.
83. Grant D. Intestinal transplantation: 1997 report of the International Registry. Intestinal Transplant Registry. Transplantation 1999;67:1061-4.
84. Rovera GM, Schoen RE, Goldbach B, et al. Intestinal and multivisceral transplantation: Dynamics of nutritional management and functional autonomy. JPEN J Parenter Enteral Nutr 2003;27:252-9.
85. Guarino A, De Marco G. Natural history of intestinal failure, investigated through a national network-based approach. J Pediatr Gastroenterol Nutr 2003;37:136-41.